Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carotid Stenting: Trials and Tribulations

Executive Summary

Today, carotid artery stenting is an accepted less-invasive alternative to surgical endarterectomy for carefully selected patients, particularly those at significant surgical risk, and market projections are very positive. But, the field still has a long way to go before this procedure is considered routine.

You may also be interested in...



Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover FDA panels' thumbs-down rulings on Styker's OP1-Putty and Therox's SuperSaturated Oxygen Therapy System, a potential curb on payments for negative pressure wound therapy pumps, CMS' review of carotid stenting coverage, and Abbott Vascular move into the second phase of its ABSORB trial for its drug-eluting stent.

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover FDA panels' thumbs-down rulings on Styker's OP1-Putty and Therox's SuperSaturated Oxygen Therapy System, a potential curb on payments for negative pressure wound therapy pumps, CMS' review of carotid stenting coverage, and Abbott Vascular move into the second phase of its ABSORB trial for its drug-eluting stent.

In Search of the Perfect Aortic Endograft

The aortic endograft market stands out in the medical device arena for its rich history of failure. The number of products that have been pulled from the market or axed before they reached it exceeds the number of models currently available in the US. But despite these past failures, endovascular aortic procedures have thrived thanks to researchers’ tenacity. At this year's International Congress on Endovascular Interventions, top surgeons discussed a number of new devices and techniques aimed at widening the scope of endovascular aortic repair to a broader range of patients.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT035061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel